At a glance
- Originator Merck & Co
- Class Antivirals
- Mechanism of Action HIV integrase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 16 Oct 2002 Discontinued - Preclinical for HIV-1 infections in USA (unspecified route)
- 22 Jun 2000 New profile
- 22 Jun 2000 Preclinical development for HIV-1 infections in USA (Unknown route)